These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 33820507)

  • 1. Anticancer Potential of Coumarin and its Derivatives.
    Bhattarai N; Kumbhar AA; Pokharel YR; Yadav PN
    Mini Rev Med Chem; 2021; 21(19):2996-3029. PubMed ID: 33820507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoformulations of Coumarins and the Hybrid Molecules of Coumarins with Potential Anticancer Effects.
    Yerer MB; Dayan S; Han MI; Sharma A; Tuli HS; Sak K
    Anticancer Agents Med Chem; 2020; 20(15):1797-1816. PubMed ID: 32156246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of coumarin bearing metal complexes: Where are we headed?
    Balcıoğlu S; Olgun Karataş M; Ateş B; Alıcı B; Özdemir İ
    Bioorg Med Chem Lett; 2020 Jan; 30(2):126805. PubMed ID: 31753700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Developments of Target Based Coumarin Derivatives as Potential Anticancer Agents.
    Goud NS; Kumar P; Bharath RD
    Mini Rev Med Chem; 2020; 20(17):1754-1766. PubMed ID: 32386492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational role of natural coumarins and their derivatives as anticancer agents.
    Menezes JC; Diederich M
    Future Med Chem; 2019 May; 11(9):1057-1082. PubMed ID: 31140865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments of C-4 substituted coumarin derivatives as anticancer agents.
    Dandriyal J; Singla R; Kumar M; Jaitak V
    Eur J Med Chem; 2016 Aug; 119():141-68. PubMed ID: 27155469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Journey and Recent Advances in the Synthesis of Coumarin Derivatives.
    Sinha S; Singh K; Ved A; Hasan SM; Mujeeb S
    Mini Rev Med Chem; 2022; 22(9):1314-1330. PubMed ID: 34784861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coumarin-benzimidazole hybrids: A review of developments in medicinal chemistry.
    G AC; Gondru R; Li Y; Banothu J
    Eur J Med Chem; 2022 Jan; 227():113921. PubMed ID: 34715585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bis-coumarin Derivatives and Their Biological Activities.
    Ren QC; Gao C; Xu Z; Feng LS; Liu ML; Wu X; Zhao F
    Curr Top Med Chem; 2018; 18(2):101-113. PubMed ID: 29473509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Literature Review on Coumarin Hybrids as Potential Anticancer Agents.
    Shaik BB; Katari NK; Seboletswe P; Gundla R; Kushwaha ND; Kumar V; Singh P; Karpoormath R; Bala MD
    Anticancer Agents Med Chem; 2023; 23(2):142-163. PubMed ID: 35440315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coumarin Compounds in Medicinal Chemistry: Some Important Examples from the Last Years.
    Pereira TM; Franco DP; Vitorio F; Kummerle AE
    Curr Top Med Chem; 2018; 18(2):124-148. PubMed ID: 29595110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Evaluation of New Coumarin Derivatives as Antioxidant, Antimicrobial, and Anti-Inflammatory Agents.
    Alshibl HM; Al-Abdullah ES; Haiba ME; Alkahtani HM; Awad GEA; Mahmoud AH; Ibrahim BMM; Bari A; Villinger A
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32708787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids.
    Kraljević TG; Harej A; Sedić M; Pavelić SK; Stepanić V; Drenjančević D; Talapko J; Raić-Malić S
    Eur J Med Chem; 2016 Nov; 124():794-808. PubMed ID: 27639370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic Mono/di-halogenated Coumarin Derivatives and Their Anticancer Properties.
    Kasumbwe K; Venugopala KN; Mohanlall V; Odhav B
    Anticancer Agents Med Chem; 2017; 17(2):276-285. PubMed ID: 27671300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coumarin-containing hybrids and their anticancer activities.
    Zhang L; Xu Z
    Eur J Med Chem; 2019 Nov; 181():111587. PubMed ID: 31404864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current developments of coumarin-based anti-cancer agents in medicinal chemistry.
    Emami S; Dadashpour S
    Eur J Med Chem; 2015 Sep; 102():611-30. PubMed ID: 26318068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoralen: A Biologically Important Coumarin with Emerging Applications.
    Thakur A; Sharma R; Jaswal VS; Nepovimova E; Chaudhary A; Kuca K
    Mini Rev Med Chem; 2020; 20(18):1838-1845. PubMed ID: 32348216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents.
    An R; Hou Z; Li JT; Yu HN; Mou YH; Guo C
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30200625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Trends in the Synthesis and Bioactivity of Coumarin, Coumarin-Chalcone, and Coumarin-Triazole Molecular Hybrids.
    Rohman N; Ardiansah B; Wukirsari T; Judeh Z
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicinal applications of coumarins bearing azetidinone and thiazolidinone moieties.
    Patil SA; Patil SA; Fariyike T; Marichev KO; Heras Martinez HM; Bugarin A
    Future Med Chem; 2021 Nov; 13(21):1907-1934. PubMed ID: 34468216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.